Amy C. Peterson is CMO at BeiGene, Ltd. (BGNE). They have made 12 open-market trades across 3 companies since 2017, most recently 2025-05-16.
CIK 0001682735
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXEL | SELL | 2025-05-16 | 2025-05-16 | $45.47 | $6.6M | -6.2% | -8.0% | -15.3% |
| CTMX | SELL | 2023-03-16 | 2023-03-20 | $1.98 | $8K | -20.0% | -8.1% | -17.3% |
| CTMX | SELL | 2022-07-20 | 2022-07-21 | $1.42 | $11K | +5.5% | +6.2% | -8.9% |
| BGNE | SELL | 2018-12-18 | 2018-12-19 | $133.75 | $1.4M | +0.8% | +6.1% | +1.2% |
| BGNE | SELL | 2018-12-17 | 2018-12-19 | $133.61 | $1.3M | +0.8% | +6.1% | +1.2% |
| BGNE | SELL | 2018-12-17 | 2018-12-19 | $133.60 | $3.8M | +0.8% | +6.1% | +1.2% |
| BGNE | SELL | 2018-11-12 | 2018-11-13 | $112.47 | $1.3M | +21.7% | +12.7% | +13.4% |
| BGNE | SELL | 2018-11-09 | 2018-11-13 | $120.37 | $1.5M | +21.7% | +12.7% | +13.4% |
| BGNE | SELL | 2018-11-08 | 2018-11-13 | $126.05 | $1.8M | +21.7% | +12.7% | +13.4% |
| BGNE | SELL | 2018-11-08 | 2018-11-13 | $121.58 | $7.3M | +21.7% | +12.7% | +13.4% |
| BGNE | SELL | 2018-08-23 | 2018-08-24 | $169.06 | $1.3M | -6.1% | -4.5% | -21.6% |
| BGNE | SELL | 2017-11-13 | 2017-11-15 | $82.96 | $598K | +7.4% | +15.4% | +50.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.